1986-1987    General Residency, Coimbra University Hospital, Coimbra, Portugal

1989-1993    Psychiatry Residency, Coimbra University Hospital, Coimbra, Portugal

1993-1994    Psychiatry Consultant, Coimbra University Hospital, Coimbra, Portugal

1996    Psychiatry Consultant, Ponta Delgada Hospital, Azores, Portugal

1997-1998    Psychiatry Consultant, Arnes Psychiatric Rehabilitation Centre, Coimbra, Portugal

1998-2010    Psychiatry Consultant, Coimbra University Hospital, Coimbra, Portugal

1998-     Assistant Professor, Faculty of Medicine, University of Coimbra, Portugal

2010-    Psychiatry Graduate Consultant, Coimbra University Hospital, Coimbra, Portugal

2010-2012        Coordinator, Psychiatry Research: Molecular Genetics Studies of Complex Disorders, Center for Neuroscience and Cell Biology, Coimbra, Portugal

2011-    Affiliated Professor, Faculty of Medicine, University of Oporto, Portugal

2011-Head of the Medical Psychology Department, Faculty of Medicine, University of Coimbra, Portugal

2011-Head of the Subacute Inpatient Unit, Coimbra Hospital and University Centre, Coimbra, Portugal

FMUC, CHUC & CNC

Genética psiquiátrica; personalidade e regulação emocional; psicoses, perturbação obsessivo-compulsiva

1.    Service S., DeYoung J., Karayiorgou M., Louw Roos J., Pretorious H., Bedoya G., Ospina J., Ruiz-Linares A., Macedo A., Almeida Palha J., Heutink P., Aulchenko Y., Oostra B., van Duijn C., Jarvelin M., Varilo T., Peddle L., Rahman P., Piras G., Monne M., Murray S., Galver L., Peltonen L., Sabatti C., Collins A., FreimerN. Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies. Nature Genetics; 38(5): 556-560- IF=24,1

2.    International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature;Sep 11;455(7210):237-41, 2008; IF=36

3.    ,International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, Aug 6;460 (7256):748-52; IF= 36,1

4.    Chen X, Lee G, Maher BS, Fanous AH, Chen J, Zhao Z, Guo A, van den Oord E, Sullivan PF, Shi J, Levinson DF, Gejman PV, Sanders A, Duan J, Owen MJ, Craddock NJ, O’Donovan MC, Blackman J, Lewis D,Kirov GK, Qin W, Schwab S,Wildenauer D, Chowdari K,Nimgaonkar V, Straub R, Weinberger DR, O’Neill A, Walsh D, Bronstein M,Darvasi A,Lencz T,Malhotra AK, Rujescu D, Giegling I, Werge T, Hansen T, Ingason A,Nöethen MM, Rietschel M, Cichon S, Djurovic S, Andreassen O, Cantor RM, Ophoff R, Corvin A, Morris DW, Gill M, Pato CN, Pato MT, Macedo A, Gurling H,McQuillin A, Pimm J, Hultman C, Lichtenstein P, Sklar P, Purcell SM, Scolnick E, St Clair D, Blackwood D, the GROUP investigators, the International Schizophrenia Consortium, Kendler KS. GWA study data-mining and independent replication identify cardiomyopathy associated 5 (CMYA5) as a risk gene for schizophrenia Molecular Psychiatry; 16(11): 117-1129, 2011; IF= 15

5.    O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, Morris D; International Schizophrenia Consortium, Corvin A.Morris DW, O'Dushlaine CT, Kenny E, Quinn EM, Gill M, Corvin A, O'Donovan MC, Kirov GK, Craddock NJ, Holmans PA, Williams NM, Georgieva L, Nikolov I, Norton N, Williams H, Toncheva D, Milanova V, Owen MJ, Hultman CM, Lichtenstein P, Thelander EF, Sullivan P, McQuillin A, Choudhury K, Datta S, Pimm J, Thirumalai S, Puri V, Krasucki R, Lawrence J, Quested D, Bass N, Gurling H, Crombie C, Fraser G, Kuan SL, Walker N, St Clair D, Blackwood DH, Muir WJ, McGhee KA, Pickard B, Malloy P, Maclean AW, Van Beck M, Wray NR, Visscher PM, Macgregor S, Pato MT, Medeiros H, Middleton F, Carvalho C, Morley C, Fanous A, Conti D, Knowles JA, Ferreira CP, Macedo A, Azevedo MH, Pato CN, Stone JL, Ruderfer DM, Ferreira MA, Purcell SM, Stone JL, Chambert K, Ruderfer DM, Kuruvilla F, Gabriel SB, Ardlie K, Daly MJ, Scolnick EM, Sklar P. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Molecular Psychiatry.16(3):286-292, 2011; IF= 15